3 Biotechs Seeking $271M IPO in the New Year Post author:Sam Post published:January 1, 2018 Post category:BioPharma Three biotech companies want to start out the new year with a new start. Source: BioSpace You Might Also Like Insmed Rockets as Lung Drug Wows in Late-Stage Study September 4, 2017 FDA Calls Regeneron's Evinacumab a Breakthrough April 5, 2017 Despite $9B Setback, Eli Lilly Boldly Moves on With Five New Alzheimer's Candidates October 25, 2017
